1. MRI for targeting: prostate
•
Prostate cancer treatment
➢
Boosting dominant intraprostatic lesions (DILs) in the
context of stereotactic ablative radiation therapy (SABR)
➢
T2-weighted, dynamic contrast-enhanced and diffusion-
weighted magnetic resonance imaging
➢
Prostate planning target volume (PTV) prescription: 42.7
Gy in 7 fractions (6.1 Gy/fr)
➢
Median PTV
DIL
prescription: 125% (range: 110%-140%)
LJ Murray et al. Prostate Stereotactic Ablative Radiation Therapy Using
Volumetric Modulated Arc Therapy to Dominant Intraprostatic Lesions.
Int J Radiation Oncol Biol Phys, Vol. 89, No. 2, pp. 406e415, 2014